Blue toe syndrome, severe haemophilia A and emicizumab.

Haemophilia

Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Published: January 2024

Download full-text PDF

Source
http://dx.doi.org/10.1111/hae.14893DOI Listing

Publication Analysis

Top Keywords

blue toe
4
toe syndrome
4
syndrome severe
4
severe haemophilia
4
haemophilia emicizumab
4
blue
1
syndrome
1
severe
1
haemophilia
1
emicizumab
1

Similar Publications

Cholesterol crystal embolism (CCE) is a rare but serious complication of atherosclerotic plaque rupture, often occurring after endovascular interventions. We report the case of a 73-year-old man who developed CCE following mechanical thrombectomy (MT) for an acute ischemic stroke (AIS) due to left internal carotid artery occlusion. The patient, with a history of hypertension and hyperlipidemia, underwent successful MT with complete recanalization.

View Article and Find Full Text PDF

Inflammatory pain, an important form of common pain, negatively influences the quality of life. Pathway-selective optogenetic control is a popular tool in neuronal function research; however, attempts to modulate rodent behavior using pathway-selective optogenetics remain unverified. We developed a methodology for pathway-selective optogenetics in rats, focusing on the delivery of recombinant adeno-associated virus (rAAV) containing channelrhodopsin-2 (ChR2) injected at the "Zusanli" acupoints to the dorsal root ganglia (DRG) and toes, which is a part of the complex neuron network.

View Article and Find Full Text PDF

Blue toe syndrome, also referred to as cholesterol crystal embolism is characterized by the distal embolization of cholesterol crystals originating from ruptured atherosclerotic plaques. This condition commonly arises in the context of cardiovascular procedures. Emboli from the thoracoabdominal aorta primarily affect the downstream extremities and intra-abdominal viscera, often resulting in fatal atheroembolic renal failure.

View Article and Find Full Text PDF
Article Synopsis
  • Various lower-limb exoskeletons can assist movement for both able-bodied individuals and those with mild to moderate gait disorders, but a universal control system for all activities doesn’t exist.
  • The paper introduces a new modular control framework that optimizes joint torques for any exoskeleton configuration in real-time during daily activities like walking, ascending stairs, or transitioning from sitting to standing.
  • The study tested this framework on eight able-bodied users with different joint setups, finding that unilateral configurations significantly reduced muscle activation during tasks, while bilateral setups showed minimal effects likely due to weight and design limitations.
View Article and Find Full Text PDF

Color-induced cognitive conflicts affect muscle activity prior to gait initiation in the Go/No-go task.

Front Hum Neurosci

October 2024

Department of Sensorimotor Neuroscience, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Introduction: In traffic rule, green/blue means go, and red means stop. It has been shown that this prior knowledge about traffic signal colors can affect reaction times (RTs). For example, RTs are longer when responding to a red "Go" signal and withholding the response to a blue "No-go" signal (Red Go/Blue No-go task) than when responding to a blue "Go" signal and withholding the response to a red "No-go" signal (Blue Go/Red No-go task), when responses are provided by button press.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!